Inflexion to sell Yumove brand owner Lintbells

Inflexion, a leading European mid-market private equity firm, is pleased to announce it has agreed to sell its investment in Lintbells, a globally recognised leader in pet supplements, to Vetnique Labs, backed by Gryphon Investors. The sale marks a highly successful exit for Inflexion Enterprise Fund IV, generating a 5.5x return.

Hertfordshire, UK-based Lintbells was founded almost two decades ago by Dr John Howie DL and John Davies, to provide pets and their owners with scientifically supported supplements to support chronic health conditions. Lintbells’ products are sold under the YuMOVE brand umbrella, encompassing the UK’s number one joint mobility supplement for dogs and cats, as well as supplements to support digestive health, anxiety, skin & coat and dental.   

Since the 2017 investment, Inflexion’s in-house teams have supported Lintbells across a range of growth opportunities, including its expansion of the highly successful direct-to-consumer channel.  Inflexion has also supported the successful expansion of Lintbells into the US both organically and through the acquisition of Walkin’ Pets. Earlier this year the firm achieved B Corp accreditation, reflecting its impressive ESG achievements. The investment period also facilitated the planned succession of Co-founder John Howie, who set the business up in 2006, with Fiona Hope brought in as Chief Commercial Officer shortly after the Inflexion investment and taking over as CEO in 2022.   

In addition to Lintbells, Inflexion has significant experience in the pet-care market with previous successful investments including Medivet and Kynetec.


View further information